Gastroenterology news & research | Hospital Healthcare Europe

This website is intended for healthcare professionals only.

Gastroenterology

Inflammatory bowel disease linked to prostate cancer

Inflammatory bowel disease linked to prostate cancer

Online CBT can help treat gastrointestinal disorders in children

Online CBT can help treat gastrointestinal disorders in children

Recommendation to continue ongoing extension study of Phase IIa trial in ulcerative colitis

Recommendation to continue ongoing extension study of Phase IIa trial in ulcerative colitis

Phase II enrollment for therapeutic vaccine candidate in patients with coeliac disease

Phase II enrollment for therapeutic vaccine candidate in patients with coeliac disease

Accuracy in predicting patient outcomes in milk oral immunotherapy

Accuracy in predicting patient outcomes in milk oral immunotherapy

Expert analysis: the importance of testing in Crohn’s disease and colitis

Expert analysis: the importance of testing in Crohn’s disease and colitis

Towards a treatment for gluten intolerance

Towards a treatment for gluten intolerance

A hope for fish allergy sufferers?

A hope for fish allergy sufferers?

NHS on track to make £300m in savings after arthritis drug deals

NHS on track to make £300m in savings after arthritis drug deals

New drug could reduce risk of allergic reaction to peanuts in children and adolescents

New drug could reduce risk of allergic reaction to peanuts in children and adolescents

$First Rare Disease Collaborative Network on refractory coeliac disease commissioned$

First Rare Disease Collaborative Network on refractory coeliac disease commissioned

Results of landmark PALISADE trial published in New England Journal of Medicine

Results of landmark PALISADE trial published in New England Journal of Medicine

Bowel cancer rates increasing across Europe

Bowel cancer rates increasing across Europe

Cannabis oil improves symptoms of Crohn’s despite no effect on gut inflammation

Cannabis oil improves symptoms of Crohn’s despite no effect on gut inflammation

Ustekinumab shows sustained efficacy in improving remission rates in Crohn’s disease over three years

Ustekinumab shows sustained efficacy in improving remission rates in Crohn’s disease over three years

Adalimumab biosimilar Imraldi launched in European Union

Adalimumab biosimilar Imraldi launched in European Union

Coeliac disease diagnosis rises to 30% – but still missing half a million

Coeliac disease diagnosis rises to 30% – but still missing half a million

x